The DOI matches its Crossref record; 219 of the 219 references it cites were found in a registry or an index.
Zero-order drug delivery: State of the art and future prospects
Abstract
Pharmaceutical drugs are an important part of the global healthcare system, with some estimates suggesting over 50% of the world's population takes at least one medication per day. Most drugs are delivered as immediate-release formulations that lead to a rapid increase in systemic drug concentration. Although these formulations have historically played an important role, they can be limited by poor patient compliance, adverse side effects, low bioavailability, or undesirable pharmacokinetics. Drug delivery systems featuring first-order release kinetics have been able to improve pharmacokinetics but are not ideal for drugs with short biological half-lives or small therapeutic windows. Zero-order drug delivery systems have the potential to overcome the issues facing immediate-release and first-order systems by releasing drug at a constant rate, thereby maintaining drug concentrations within the therapeutic window for an extended period of time. This release profile can be used to limit adverse side effects, reduce dosing frequency, and potentially improve patient compliance. This review covers strategies being employed to attain zero-order release or alter traditionally first-order release kinetics to achieve more consistent release before discussing opportunities for improving device performance based on emerging materials and fabrication methods.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–219 of 219
Nanofibrous and nanoparticle materials as drug-delivery systems
Zamani, F., Jahanmard, F., Ghasemkhah, F., Amjad‐Iranagh, S., Bagherzadeh, R., Tehran, M. A., & Latifi, M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46143-6.00007-5 · Cited by 30
Rey-Viñolas, S., Engel, E., & Mateos‐Timoneda, M. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-08-102451-5.00007-x · Cited by 29
Clinical Applications of Biomedical Microdevices for Controlled Drug Delivery
Gurman, P., Miranda, O. R., Clayton, K., Rosen, Y., & Elman, N. M. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2014.10.003 · Cited by 29
Long-Term Biocompatibility of NanoGATE Drug Delivery Implant
Walczak, R. J., Boiarski, A. A., Cohen, M., West, T., Melnik, K., Shapiro, J. P., Sharma, S., & Mauro Ferrari, B. (2005) · Nanobiotechnology · doi:10.1385/nbt:1:1:035 · Cited by 27
Microsphere delivery of Risperidone as an alternative to combination therapy
D’Souza, S. S., Faraj, J. A., & DeLuca, P. P. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.07.012 · Cited by 27
Candidate's Thesis: Polymer Chemotherapy for Head and Neck Cancer
Shikani, A. H., & Domb, A. J. (2000) · The Laryngoscope · doi:10.1097/00005537-200006000-00004 · Cited by 26
Chaw, C. S., Yang, Y., Lim, I. J., et al. (2003) · Journal of Microencapsulation · doi:10.3109/02652040309178074 · Cited by 21
Dubey, A., Prabhu, P., Parth, V., & Ghate, V. (2015) · International Journal of Pharmaceutical Investigation · doi:10.4103/2230-973x.167684 · Cited by 20
Turek, A., Olakowska, E., Borecka, A., Janeczek, H., Sobota, M., Jaworska, J., Kaczmarczyk, B., Jarząbek, B., Gruchlik, A., Libera, M., et al. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-2019-9 · Cited by 20
Preparation and characterization of protein-loaded polyanhydride microspheres
Sun, L., Zhou, S., Wang, W., Su, Q., Li, X., & Weng, J. (2009) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-009-3765-6 · Cited by 19
Liu, R., Wang, Y., Ma, Y., Wu, Y., Guo, Y., & Xu, L. (2016) · Chemical Research in Chinese Universities · doi:10.1007/s40242-016-6155-x · Cited by 19
Enzymatic activity preservation and protection through entrapment within degradable hydrogels
Mariani, A. M., Natoli, M. E., & Kofinas, P. (2013) · Biotechnology and Bioengineering · doi:10.1002/bit.24971 · Cited by 18
Effect of Fabrication Technique on the Erosion Characteristics of Polyanhydride Matrices
Javar, H. A., D’Emanuele, A., & Attwood, D. (1998) · Pharmaceutical Development and Technology · doi:10.3109/10837459809028502 · Cited by 18
Implantable micro-chip for controlled delivery of diclofenac sodium
Lee, S. H., Park, M., Park, C. G., Kim, B.-H., Lee, J., Choi, S.-Y., Nam, S.-R., Park, S., & Choy, Y. B. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.09.019 · Cited by 16
Thakkar, H. P., Pancholi, N., & Patel, C. (2015) · AAPS PharmSciTech · doi:10.1208/s12249-015-0463-1 · Cited by 16
Contraceptive vaginal ring experiences among women and men in Kisumu, Kenya: A qualitative study
McLellan–Lemal, E., Ondenge, K., Gust, D. A., Desai, M. R., Otieno, F., Madiega, P. A., Nyagol, B., & Makanga, M. (2017) · Frontiers in Women’s Health · doi:10.15761/fwh.1000122 · Cited by 14
Design of Salbutamol EOP Tablets from Pharmacokinetics Parameters
Sinchaipanid, N., Pongwai, S., Limsuwan, P., et al. (2003) · Pharmaceutical Development and Technology · doi:10.1081/pdt-120018479 · Cited by 11
Prescription medicines: did you know...?
La, R., Bm, D., & Tj, I. (1992) · PubMed · Cited by 9
Lu (1999) · doi:10.1002/(sici)1097-4636(199908)46:2
Cited by
Drug release study of the chitosan-based nanoparticles
Herdiana, Y., Wathoni, N., Shamsuddin, S., & Muchtaridi, M. (2022) · Heliyon · doi:10.1016/j.heliyon.2021.e08674 · Cited by 576
“However, excessive release can reduce the therapeutic efficacy, resulting in delayed drug delivery [28].”
BackgroundOvercoming barriers to patient adherence: the case for developing innovative drug delivery systems
Baryakova, T. H., Pogostin, B. H., Langer, R., & McHugh, K. J. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00670-0 · Cited by 492
Self-citationKinetic Modeling to Explain the Release of Medicine from Drug Delivery Systems
Askarizadeh, M., Esfandiari, N., Honarvar, B., Sajadian, S. A., & Azdarpour, A. (2023) · ChemBioEng Reviews · doi:10.1002/cben.202300027 · Cited by 318
Designing spatial and temporal control of vaccine responses
Roth, G. A., Picece, V. C. T. M., Ou, B. S., Luo, W., Pulendran, B., & Appel, E. A. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00372-2 · Cited by 316
Recent Applications of PLGA in Drug Delivery Systems
Yang, J., Zeng, H., Luo, Y., Chen, Y., Wang, M., Wu, C., & Hu, P. (2024) · Polymers · doi:10.3390/polym16182606 · Cited by 268
Metadata
- Authors
- Laracuente, M.-L., Yu, M. H., & McHugh, K. J.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2020-11
- Volume
- 327
- Pages
- 834-856
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W3086057753
- Cited by
- 384
- References
- 219
- FWCI
- 9.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.